ClinicalTrials.gov record
Terminated Phase 3 Interventional

Calfactant for Direct Acute Respiratory Distress Syndrome

ClinicalTrials.gov ID: NCT00682500

Public ClinicalTrials.gov record NCT00682500. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 8:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Calfactant Therapy for Direct Acute Respiratory Distress Syndrome & Direct Acute Lung Injury in Adults and Children

Study identification

NCT ID
NCT00682500
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pneuma Pharmaceuticals Incorporated
Other
Enrollment
332 participants

Conditions and interventions

Interventions

  • Calfactant Drug
  • Room Air (placebo) Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2008
Primary completion
Nov 30, 2010
Completion
Jan 31, 2011
Last update posted
Jul 23, 2012

2008 – 2011

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
University of Florida Gainesville Florida
Florida Hospital and Florida Children's Hospital Orlando Florida
Northwestern University-Chicago Chicago Illinois
West Suburban Hospital Medical Center Oak Park Illinois
Peoria Pulmonary Associates/OSF St. Francis Hospital Peoria Illinois
Clarian Health, Inc/Methodist Hospital Indianapolis Indiana
University of Iowa Iowa City Iowa
Creighton University Omaha Nebraska 68131
Omaha Children's Hospital Omaha Nebraska 68198
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire
Columbia Medical Center--Pediatrics New York New York
The Oregon Clinic Portland Oregon
Penn State University Hershey Pennsylvania
Baylor College of Medicine/Texas Children's Hospital Houston Texas
Uthscsa/Stvah San Antonio Texas
University of Virginia Health Science Center Charlottesville Virginia 22908
INOVA Fairfax Hospital Fairfax Virginia
Medical College of Wisconsin Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00682500, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 23, 2012 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00682500 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →